trending Market Intelligence /marketintelligence/en/news-insights/trending/EOD2c3yajYKADseoHswAFQ2 content esgSubNav
In This List

Global Blood Therapeutics closes $100M common stock offering

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Global Blood Therapeutics closes $100M common stock offering

Global Blood Therapeutics Inc. closed its underwritten public offering of 2,631,579 common shares at $38 per share for expected gross proceeds of about $100 million.

In addition, the underwriters including Cantor Fitzgerald & Co., acting as a representative of the several underwriters, have a 30-day option to buy 394,736 additional common shares.